Sara Tolaney
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Sara Tolaney
Oct 9, 2024, 14:00 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Sara Tolaney
We are excited to introduce Dr. Sara Tolaney, a leading expert in breast oncology, as…
Oct 6, 2024, 07:42 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
This week, we continue featuring 100 influential women in oncology, and here is the list…
Sep 20, 2024, 13:00 |
Blog
The 1st webinar of the ’24-‘25 EMBRACE Metastatic Breast Cancer Forum Series - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on X: ''Join Nancy Lin, and Sara Tolaney, via Zoom for…
Sep 18, 2024, 23:03 |
Insight
Aleix Prat: Dual HER2 inhibition in Breast Cancer
Aleix Prat shared a post on X about a recent paper by Adrienne Waks et…
Sep 10, 2024, 10:45 |
Blog
Sara Tolaney: Mark your calendars for PER’s School of Breast Oncology
Sara Tolaney shared a post on X: “Mark your calendars for PER’s School of Breast…
Sep 7, 2024, 19:36 |
Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Sep 6, 2024, 11:25 |
Insight
Paolo Tarantino: Interesting RWA of outcomes with chemotherapy in HR+/HER2- MBC
Paolo Tarantino shared a post by ESMO Open on X, adding: "Interesting real world analysis…
Sep 1, 2024, 15:26 |
Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Jul 26, 2024, 00:18 |
Blog
Sara Tolaney on novel therapies for young women with breast cancer at Young Women's Forum
Young Women's Forum shared on X: "Honored to have Sara Tolaney, Chief of Breast Oncology…
Jul 25, 2024, 08:58 |
Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 14, 2024, 21:42 |
Blog
Paolo Tarantino: Stellar Tumor Board session at the Harvard Medical School Breast Course
Paolo Tarantino shared a post on X: ''Stellar Tumor Board session at the Harvard Medical…
Jul 12, 2024, 20:47 |
Societies
Stuart Schnitt on the future of breast pathology with the potential benefits of AI
Sara Tolaney shared on X: "Dr Stuart Schnitt does an outstanding job highlighting the future…
Jul 5, 2024, 05:41 |
Blog
Abeid Athman: Joining ASCO had a huge role in shaping my career
Abeid Athman, Clinical Oncologist at Kenyatta University Hospital, shared on X: "It has been 5…
Jul 3, 2024, 22:59 |
Blog
Aleix Prat: Our 2 articles published this week
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared on X:…
Jul 3, 2024, 10:44 |
Blog
Abeid M. Athman Omar: The last four months have been very eventful for me
Abeid M. Athman Omar, Clinical Oncology Specialist at Kenyatta University, shared a post on LinkedIn: "The last…
Jul 3, 2024, 01:24 |
Blog
Paolo Tarantino: ATEMPT would have not been possible without the vision of Sara Tolaney
Sara Tolaney shared a post by Paolo Tarantino on X: “Very lucky to get to…
Jul 2, 2024, 10:32 |
Insight
Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA
MedEdge MEA shared a post on LinkedIn: . "A year of treatment with a medicine…
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 26, 2024, 03:41 |
Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X: . "Early recurrent TNBC (Triple-Negative…
Jun 22, 2024, 04:43 |
Blog
Sara Tolaney: Please consider attending the School of Breast Oncology
Hope Rugo, Medical hematologist-oncologist at UCSF, shared a post by Sara Tolaney, on X: ''It is indeed.…
Jun 11, 2024, 15:21 |
Blog
Abeid M. Athman Omar: Delighted to have received two awards at the ASCO24 meeting
Abeid M. Athman Omar, Clinical Oncology Specialist at Kenyatta University, shared a post on LinkedIn: ''I am…
May 31, 2024, 18:51 |
Blog
Sameh Abdelmalak: Dr. Sara Tolaney and Dr. Hope Rugo discussing ASCO24 Noteworthy Abstracts in Breast Cancer
Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X: "Check…
May 22, 2024, 08:48 |
Blog
SITC will host the free Summit on Immunomodulation of ADCs
Society for Immunotherapy of Cancer shared a post on X: “SITC will host the free Summit…
May 20, 2024, 13:16 |
Career
Sara Tolaney is appointed as Alliance for Clinical Trials in Oncology Breast Committee Vice-Chair
Alliance for Clinical Trials in Oncology recently shared on X: "Congratulations to Sara Tolaney, MD,…
May 18, 2024, 10:02 |
Societies
Matteo Lambertini: What a big honor to have Sara Tolaney at our ESMOYOC session
Matteo Lambertini, Medical Oncologist at San Martino, shared on X: . "What a big honor…
May 18, 2024, 09:54 |
Societies
Paolo Tarantino: Why was IMpassion132 negative?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
May 18, 2024, 08:12 |
Blog
Paolo Tarantino: Sara Tolaney recapitulating 10+ years of de-escalation trials
Paolo Tarantino shared a post on X/Twitter: ''Terrific presentation by Sara Tolaney at ESMO Breast24, recapitulating…
May 18, 2024, 04:17 |
Blog
Sara Tolaney: Interesting data from Mafalda Oliveira from SERENA-2 at ESMO Breast24
Sara Tolaney shared a post on X: ''Interesting data from Mafalda Oliveira from SERENA-2 demonstrating…
May 17, 2024, 11:41 |
Insight
Sara Tolaney: Helpful discussion by Cristina Saura on how to think about adjuvant therapies in patients with gBRCAm
Sara Tolaney shared a post on X: “Very helpful discussion by Cristina Saura on how…
May 14, 2024, 16:00 |
Blog
Dr. Sara Tolaney will be the invited discussant for three excellent Breast Cancer trials at ESMO Breast 24 - Dana Farber’s Breast Oncology Center
Dana Farber’s Breast Oncology Center shared a post on X: “Check out the ESMO Breast 24…
May 7, 2024, 11:51 |
Positive
Sara Tolaney: HAPPY NURSES WEEK!
Sara Tolaney shared a post on X: "HAPPY NURSES WEEK! A special thank you to…
May 7, 2024, 03:53 |
Blog
Aleix Prat: Dr. Tomás Pascual, will be co-presenting an educational talk alongside Sara Tolaney and Tatiana Prowell
Aleix Prat, Director of the Oncology Institute at Hospital Clínic Barcelona, shared a post on X:…
May 5, 2024, 06:21 |
Blog
Sara Tolaney discussed the new breast cancer screening guidelines - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on their X/Twitter: ''Sara Tolaney discussed the new breast cancer…
May 1, 2024, 13:41 |
Opinion
Sara Tolaney: Such an important question addressed in the Alliance A011502 study
Sara Tolaney shared a post by Erman Akkus, Medical Oncology Fellow at Ankara University, on X/Twitter: "Such…
Apr 22, 2024, 11:40 |
Blog
Sara Tolaney: Very excited to have Aleix Prat as the Schlager Lecturer at the Harvard Breast Course in July!
Sara Tolaney shared a post by Aleix Prat, Co-Founder of Reveal Genomics, on X/Twitter, adding:…
Mar 24, 2024, 08:23 |
Drugs
Paolo Tarantino: Adding palbociclib to fulvestrant did not improve PFS in the PACE randomized phase 2 trial
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Feb 27, 2024, 15:28 |
Blog
Dr. Sara Tolaney discusses Antibody Drug Conjugates - Dana-Farber’s Breast Oncology Center
Quoting Dana-Farber’s Breast Oncology Center on X/Twitter: "Dr. Sara Tolaney discusses Antibody Drug Conjugates in…
Feb 14, 2024, 13:13 |
Blog
Chiara Corti: Thanks so much to Gianni Bonadonna Foundation and AIRC Foundation for cancer research for this opportunity
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post by Gianni Bonadonna Foundation…
Dec 17, 2023, 17:26 |
Blog
25 Posts Not To Miss From SABCS 2023
The San Antonio Breast Cancer Symposium 2023 (SABCS 2023) took place in San Antonio, Texas…
Dec 8, 2023, 17:54 |
Career
Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
Dana-Farber News /Dana Farber Cancer Institute/ shared on their X/Twitter account: "Congrats to Dana-Farber Cancer…
Nov 1, 2023, 18:54 |
Societies
20 Posts Not To Miss From ESMO 2023 Congress
The Annual Congress of the European Society For Medical Oncology (ESMO) took place from October…
Oct 21, 2023, 21:40 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 9
We continue OncoDaily’s ‘100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
Oct 13, 2023, 17:39 |
Blog
Sara Tolaney: Consider applying to the Gilead Research Scholars program if you are a junior faculty member looking for funding for research in solid tumors!
Quoting Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, on…
Sep 15, 2023, 18:51 |
Blog
Michail Ignatiadis: Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic & Program, Jules Bordet Institute, on…
Aug 25, 2023, 18:26 |
Insight
Sara Tolaney: TROPICS-02 Overall Survival data now published in The Lancet!
Quoting Sara Tolaney, Chief of Division of Breast Oncology at Dana Farber Cancer Institute, on…
Aug 14, 2023, 17:39 |
Insight
Check out the new review just published in Cancers MDPI on Tumor Mutational Burden in Breast Cancer - Dana-Farber’s Breast Oncology Center
Quoting from a recent tweet by Dana-Farber’s Breast Oncology Center: "Check out the new review…
All:
46
Posts:
1 - 100
Janet Woodcock has joined the Board of Directors of Every Cure
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube